Last reviewed · How we verify

Berberine Treat Metabolic Syndrome in Schizophrenia

NCT03251716 NA COMPLETED

In early clinical study investigators confirmed that berberine could prevent glucose and lipid metabolism disorder in schizophrenia, so investigators intend to verify the effect and safety of berberine in treatment for metabolic syndrome in schizophrenia.

Details

Lead sponsorTianjin Anding Hospital
PhaseNA
StatusCOMPLETED
Enrolment36
Start dateThu Jan 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
CompletionSat Dec 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Interventions

Countries

China